State of Wisconsin Investment Board’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

State of Wisconsin Investment Board’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-36,800	Closed	-$465K	–	2102
2020 Q4	$465K	Sell	36,800 -4,600	-11%	-$52.4K	﹤0.01%	1561
2020 Q3	$407K	Hold	41,400	–	–	﹤0.01%	1551
2020 Q2	$412K	Hold	41,400	–	–	﹤0.01%	1480
2020 Q1	$366K	Buy	41,400 +9,100	+28%	+$89.7K	﹤0.01%	1428
2019 Q4	$298K	Hold	32,300	–	–	﹤0.01%	1545
2019 Q3	$190K	Buy	32,300 +3,200	+11%	+$34K	﹤0.01%	1506
2019 Q2	$349K	Buy	29,100 +600	+2%	+$6.45K	﹤0.01%	1410
2019 Q1	$344K	Buy	28,500 +6,500	+30%	+$95.8K	﹤0.01%	1409
2018 Q4	$276K	Buy	22,000 +9,000	+69%	+$124K	﹤0.01%	1421
2018 Q3	$193K	Hold	13,000	–	–	﹤0.01%	1503
2018 Q2	$219K	Hold	13,000	–	–	﹤0.01%	1419
2018 Q1	$298K	Hold	13,000	–	–	﹤0.01%	1364
2017 Q4	$336K	Hold	13,000	–	–	﹤0.01%	1346
2017 Q3	$192K	Hold	13,000	–	–	﹤0.01%	1400
2017 Q2	$181K	Buy	+13,000	New	+$192K	﹤0.01%	1407

Other funds holding CNCE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wisconsin Investment Board's CNCE Position: Q1 2021 in Review

State of Wisconsin Investment Board sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2021, closing a stake of 36,800 shares — an estimated $465K sold.

State of Wisconsin Investment Board first reported a position in CNCE in Q2 2017 and held it in 15 quarters. The position peaked at $465K in Q4 2020. 91 funds tracked by Wall St. Rank hold CNCE as of Q1 2021.

State of Wisconsin Investment Board reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 36,800 Concert Pharmaceuticals, Inc. shares in Q1 2021, an estimated $465K.
State of Wisconsin Investment Board first reported a position in Concert Pharmaceuticals, Inc. in Q2 2017 and held it in 15 quarters.
State of Wisconsin Investment Board's Concert Pharmaceuticals, Inc. position peaked at $465K in Q4 2020.
91 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2021, filed 17 May 2021.